GB0322395D0 - Methods for treating bladder dysfunction and related compounds and compositions - Google Patents

Methods for treating bladder dysfunction and related compounds and compositions

Info

Publication number
GB0322395D0
GB0322395D0 GB0322395A GB0322395A GB0322395D0 GB 0322395 D0 GB0322395 D0 GB 0322395D0 GB 0322395 A GB0322395 A GB 0322395A GB 0322395 A GB0322395 A GB 0322395A GB 0322395 D0 GB0322395 D0 GB 0322395D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
related compounds
bladder dysfunction
treating bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0322395A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxell SpA
Original Assignee
Bioxell SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxell SpA filed Critical Bioxell SpA
Priority to GB0322395A priority Critical patent/GB0322395D0/en
Publication of GB0322395D0 publication Critical patent/GB0322395D0/en
Priority to US10/903,211 priority patent/US7332482B2/en
Priority to SG200404316A priority patent/SG110107A1/en
Priority to CA002476224A priority patent/CA2476224A1/en
Priority to AU2004203436A priority patent/AU2004203436A1/en
Priority to PT103177A priority patent/PT103177A/en
Priority to CH01553/04A priority patent/CH698144B1/en
Priority to BR0404050-3A priority patent/BRPI0404050A/en
Priority to FR0410073A priority patent/FR2859910B1/en
Priority to NZ535531A priority patent/NZ535531A/en
Priority to EA200401100A priority patent/EA010240B1/en
Priority to NL1027109A priority patent/NL1027109C2/en
Priority to BRPI0414701-4A priority patent/BRPI0414701A/en
Priority to EP04765598A priority patent/EP1673096A1/en
Priority to PCT/US2004/031532 priority patent/WO2005030223A1/en
Priority to CA002539708A priority patent/CA2539708A1/en
Priority to CNA2008102125148A priority patent/CN101352446A/en
Priority to EP04789064A priority patent/EP1663250A4/en
Priority to BE2004/0472A priority patent/BE1016292A3/en
Priority to AU2004275815A priority patent/AU2004275815A1/en
Priority to PCT/US2004/031412 priority patent/WO2005030222A1/en
Priority to CNB2004100800817A priority patent/CN100488511C/en
Priority to JP2006527365A priority patent/JP2007506699A/en
Priority to JP2006528270A priority patent/JP2007506780A/en
Priority to CN 200480034602 priority patent/CN1886140A/en
Priority to US10/572,995 priority patent/US20080064668A1/en
Priority to AU2004275845A priority patent/AU2004275845A1/en
Priority to JP2006528227A priority patent/JP2007506765A/en
Priority to EP04789014A priority patent/EP1663249A4/en
Priority to PCT/EP2004/010760 priority patent/WO2005027923A1/en
Priority to US10/573,164 priority patent/US20070054887A1/en
Priority to CA002540325A priority patent/CA2540325A1/en
Priority to HK05108113.0A priority patent/HK1085373A1/en
Priority to ZA200602097A priority patent/ZA200602097B/en
Priority to IL174369A priority patent/IL174369A0/en
Priority to US11/386,494 priority patent/US20060258630A1/en
Priority to IL174484A priority patent/IL174484A0/en
Priority to US11/977,502 priority patent/US20080207769A1/en
Priority to AU2008203397A priority patent/AU2008203397A1/en
Priority to JP2008209429A priority patent/JP2009035559A/en
Ceased legal-status Critical Current

Links

GB0322395A 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions Ceased GB0322395D0 (en)

Priority Applications (40)

Application Number Priority Date Filing Date Title
GB0322395A GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions
PT103177A PT103177A (en) 2003-09-24 2004-07-29 1-ALPHA-FLUORO-25-HYDROXY-16,23E-DIENE-26,27-BIS-HOMO-20-EPI-COLECALCIFEROL, ITS SALTS OR ESTERS AND ITS USE IN THE MANUFACTURE OF MEDICINES
AU2004203436A AU2004203436A1 (en) 2003-09-24 2004-07-29 Compound and use in treatment
SG200404316A SG110107A1 (en) 2003-09-24 2004-07-29 Compound and use in treatment
CA002476224A CA2476224A1 (en) 2003-09-24 2004-07-29 Compound and use in treatment
US10/903,211 US7332482B2 (en) 2003-09-24 2004-07-29 Method for treating benign prostatic hyperplasia
CH01553/04A CH698144B1 (en) 2003-09-24 2004-09-22 Analogue of vitamin D3
BR0404050-3A BRPI0404050A (en) 2003-09-24 2004-09-22 Use of a compound or pharmaceutically acceptable salt or ester thereof, pharmaceutical formulation, packaged formulation, compound, and method for preventing and / or treating benign prostate hyperplasia in patients in need of such prevention or treatment.
FR0410073A FR2859910B1 (en) 2003-09-24 2004-09-23 USE OF 1-ALPHA-FLUORO-25-HYDROXY-16,23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
NZ535531A NZ535531A (en) 2003-09-24 2004-09-23 Compound and use in treatment
EA200401100A EA010240B1 (en) 2003-09-24 2004-09-23 1-alpha-fluoro-25-hydroxy-16,23e-diene-26,27-bishomo-20-epicholecalciferol and use for treatment thereof
CA002540325A CA2540325A1 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
BE2004/0472A BE1016292A3 (en) 2003-09-24 2004-09-24 CONNECTION AND USE IN TREATMENT.
AU2004275845A AU2004275845A1 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
EP04765598A EP1673096A1 (en) 2003-09-24 2004-09-24 Use of a vitamin d3 analogue for the treatment of benign prostatic hyperplasia
PCT/US2004/031532 WO2005030223A1 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
CA002539708A CA2539708A1 (en) 2003-09-24 2004-09-24 1,3-diaclyated,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CNA2008102125148A CN101352446A (en) 2003-09-24 2004-09-24 Compound and use for the treatment of benign prostatic hyperplasia and relative diseases
EP04789064A EP1663250A4 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
NL1027109A NL1027109C2 (en) 2003-09-24 2004-09-24 Connection and use with treatment.
AU2004275815A AU2004275815A1 (en) 2003-09-24 2004-09-24 1,3-diaclyated,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
PCT/US2004/031412 WO2005030222A1 (en) 2003-09-24 2004-09-24 1,3-diaclyated,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CNB2004100800817A CN100488511C (en) 2003-09-24 2004-09-24 Compound and use for preparation of the medicament for treatment of benign prostatic hyperplasia and relative diseases
JP2006527365A JP2007506699A (en) 2003-09-24 2004-09-24 Use of vitamin D3 analogs for the treatment of benign prostatic hyperplasia
JP2006528270A JP2007506780A (en) 2003-09-24 2004-09-24 Method for treating bladder dysfunction
CN 200480034602 CN1886140A (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
US10/572,995 US20080064668A1 (en) 2003-09-24 2004-09-24 1,3-Diacylated, 26,27-Alkyl/Haloakyl Vitamin D3 Compounds and Methods of Use Thereof
BRPI0414701-4A BRPI0414701A (en) 2003-09-24 2004-09-24 use of a vitamin d compound, method of prevention or treatment of bladder dysfunction in a patient, vitamin d compound e, kit
JP2006528227A JP2007506765A (en) 2003-09-24 2004-09-24 1,3-diacylated 26,27-alkyl / haloalkylvitamin D3 compounds and methods of use thereof
EP04789014A EP1663249A4 (en) 2003-09-24 2004-09-24 1,3-DIACLYATED,26,27-ALKYL/HALOALKYL VITAMIN D sb 3 /sb COMPOUNDS AND METHODS OF USE THEREOF
PCT/EP2004/010760 WO2005027923A1 (en) 2003-09-24 2004-09-24 Use of vitamin d3 analogue for the treatment of benign prostatic hyperplasia
US10/573,164 US20070054887A1 (en) 2003-09-24 2004-09-24 Methods for treating bladder dysfunction
HK05108113.0A HK1085373A1 (en) 2003-09-24 2005-09-16 Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms
ZA200602097A ZA200602097B (en) 2003-09-24 2006-03-13 Methods for treating bladder dysfunction
IL174369A IL174369A0 (en) 2003-09-24 2006-03-16 Methods for treating bladder dysfunction
US11/386,494 US20060258630A1 (en) 2003-09-24 2006-03-21 Method for the prevention and treatment of uveitis
IL174484A IL174484A0 (en) 2003-09-24 2006-03-22 1,3-diacylated, 26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
US11/977,502 US20080207769A1 (en) 2003-09-24 2007-10-24 Method for treating benign prostatic hyperplasia
AU2008203397A AU2008203397A1 (en) 2003-09-24 2008-07-30 Compound and use in treatment
JP2008209429A JP2009035559A (en) 2003-09-24 2008-08-18 Use of vitamin d3 analog for the treatment of benign prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0322395A GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions

Publications (1)

Publication Number Publication Date
GB0322395D0 true GB0322395D0 (en) 2003-10-22

Family

ID=29266605

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0322395A Ceased GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions

Country Status (3)

Country Link
CN (2) CN1886140A (en)
GB (1) GB0322395D0 (en)
ZA (1) ZA200602097B (en)

Also Published As

Publication number Publication date
CN101352446A (en) 2009-01-28
CN1886140A (en) 2006-12-27
ZA200602097B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
HK1219678A1 (en) Methods for treating interleukin-6 related diseases -6
GB2423928B (en) Methods and compositions for treating pain
HK1121952A1 (en) Methods and compositions for treating conditions
IL241756A0 (en) Compositions and methods for treating neoplastic diseases
AP2089A (en) Compositions and methods for combination antiviraltherapy
EP1633718A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING TGF-s
EP1737482A4 (en) Compositions and methods for treating diseases
IL176259A0 (en) Compositions and methods for treating diabetes
HK1214158A1 (en) Formulations and methods for treating amyloidosis
IL176919A0 (en) Methods and compositions for treating cancer
EP1680535A4 (en) Electroplating compositions and methods for electroplating
EP1725237A4 (en) Methods for treating alcoholism
IL175345A0 (en) Methods and compositions for selectin inhibition
IL174369A0 (en) Methods for treating bladder dysfunction
EP1742629A4 (en) Methods for treating alcoholism
IL175389A0 (en) Methods and compositions for selectin inhibition
EP1626711A4 (en) Compositions and methods for treating cancer
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
GB0322395D0 (en) Methods for treating bladder dysfunction and related compounds and compositions
GB0404567D0 (en) Methods for treating bladder dysfunction and related compounds and compositions
AU2003214606A8 (en) Compositions and methods for treating mdma-induced toxicity
EP1608316A4 (en) Methods and compositions for treating and preventing inflammatory conditions
AU2003277296A8 (en) Compositions and methods for treating sexual dysfunction
ZA200603684B (en) Methods and compositions for selectin inhibition
IL174519A0 (en) Compositions and methods using same for treating amyloid associated diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)